Healthcare Service Provider Tenet Healthcare's Q3 Earnings Beat On Higher Volumes; Tightens Guidance

Tenet Healthcare Corp THC reported Q3 net operating income of $101 million ($0.94 per diluted share), down from the $131 million ($1.16 per diluted share) in the prior year

Q3 adj EPS was $1.44, beating the consensus of $1.20 and up from $1.42 a year ago.

Net operating revenues for the quarter came in at $5.07 billion, up from $4.80 billion, beating the consensus of $5.02 billion.

United Surgical Partners International, the ambulatory business, Tenet reported $941 million in Q3 net operating revenues, up year over year from $806 million, driven by strong same-facility net surgical case growth, acquisitions, and opening of de novo facilities, service line growth, and improved pricing yield.

Same-facility surgical cases rose 4.1% year over year.

Among its acute care hospitals, Tenet’s net operating revenues rose 3.7% year over year, from $3.78 billion to $3.92 billion, due to a combination of higher adjusted admissions and improved pricing yield.

Same-hospital and adjusted admissions rose 0.6% and 0.4% year over year, respectively, though outpatient visits fell 2%, ER visits dipped 0.9%, and hospital surgeries fell 0.7%. 

Guidance: Tenet sees Q4 net operating revenue projections at $5.13 billion-$5.33 billion versus consensus of $5.24 billion

The company sees Q4 adjusted EPS of $1.12-$1.74 compared to consensus of $1.75.

For FY23, Tenet projects revenues of $20.3 billion -$20.5 billion compared to prior guidance of $20.1 billion-$20.5 billion and consensus of $20.4 billion.

The company forecasts FY23 adjusted EPS of $5.43-$6.05 versus prior guidance of $5.18-$6.03 and consensus of $5.81.

Price Action: THC shares are down 0.32% at $55.08 on the last check Tuesday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareMoversGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!